Japan's Mitsui Acquires Stake In India's Arch Pharma For Direct Presence In The "Global Factory"
This article was originally published in PharmAsia News
Executive Summary
HYDERABAD, India - After Japanese drug giants Daiichi Sankyo, Eisai, Astellas and Takeda, it is the turn of Mitsui - one of the largest and most diverse Japanese industry conglomerates - to evince a direct interest in the Indian pharmaceutical industry